These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Comparative transcriptional profiling of the early host response to infection by typhoidal and non-typhoidal Salmonella serovars in human intestinal organoids. Abuaita BH; Lawrence AE; Berger RP; Hill DR; Huang S; Yadagiri VK; Bons B; Fields C; Wobus CE; Spence JR; Young VB; O'Riordan MX PLoS Pathog; 2021 Oct; 17(10):e1009987. PubMed ID: 34669717 [TBL] [Abstract][Full Text] [Related]
4. Salmonella enterica Serovar Typhimurium Exploits Cycling through Epithelial Cells To Colonize Human and Murine Enteroids. Geiser P; Di Martino ML; Samperio Ventayol P; Eriksson J; Sima E; Al-Saffar AK; Ahl D; Phillipson M; Webb DL; Sundbom M; Hellström PM; Sellin ME mBio; 2021 Jan; 12(1):. PubMed ID: 33436434 [TBL] [Abstract][Full Text] [Related]
5. Identification of salmonella pathogenicity island-2 type III secretion system effectors involved in intramacrophage replication of S. enterica serovar typhimurium: implications for rational vaccine design. Figueira R; Watson KG; Holden DW; Helaine S mBio; 2013 Apr; 4(2):e00065. PubMed ID: 23592259 [TBL] [Abstract][Full Text] [Related]
6. Deletion of invH gene in Salmonella enterica serovar Typhimurium limits the secretion of Sip effector proteins. Pati NB; Vishwakarma V; Jaiswal S; Periaswamy B; Hardt WD; Suar M Microbes Infect; 2013 Jan; 15(1):66-73. PubMed ID: 23159244 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of the Type III Secretion System of Salmonella enterica Serovar Typhimurium via Treatment with Fraxetin. Shi Y; Sun Z; Liu Y; Shu J; Zhang Y; Lv Q; Wang J; Deng X; Liu H; Qiu J Microbiol Spectr; 2022 Dec; 10(6):e0294922. PubMed ID: 36377917 [TBL] [Abstract][Full Text] [Related]
8. Salmonella translocates across an in vitro M cell model independently of SPI-1 and SPI-2. Martinez-Argudo I; Jepson MA Microbiology (Reading); 2008 Dec; 154(Pt 12):3887-3894. PubMed ID: 19047755 [TBL] [Abstract][Full Text] [Related]
9. QseC mediates Salmonella enterica serovar typhimurium virulence in vitro and in vivo. Moreira CG; Weinshenker D; Sperandio V Infect Immun; 2010 Mar; 78(3):914-26. PubMed ID: 20028809 [TBL] [Abstract][Full Text] [Related]
10. Alghoribi MF; Doumith M; Alrodayyan M; Al Zayer M; Köster WL; Muhanna A; Aljohani SM; Balkhy HH; Desin TS Front Cell Infect Microbiol; 2019; 9():187. PubMed ID: 31214517 [TBL] [Abstract][Full Text] [Related]
11. Differences in the expression of SPI-1 genes pathogenicity and epidemiology between the emerging Salmonella enterica serovar Infantis and the model Salmonella enterica serovar Typhimurium. Aviv G; Cornelius A; Davidovich M; Cohen H; Suwandi A; Galeev A; Steck N; Azriel S; Rokney A; Valinsky L; Rahav G; Grassl GA; Gal-Mor O J Infect Dis; 2019 Aug; 220(6):1071-1081. PubMed ID: 31062854 [TBL] [Abstract][Full Text] [Related]
12. Net replication of Salmonella enterica serovars Typhimurium and Choleraesuis in porcine intestinal mucosa and nodes is associated with their differential virulence. Paulin SM; Jagannathan A; Campbell J; Wallis TS; Stevens MP Infect Immun; 2007 Aug; 75(8):3950-60. PubMed ID: 17548482 [TBL] [Abstract][Full Text] [Related]
13. Differences in Host Cell Invasion and Salmonella Pathogenicity Island 1 Expression between Salmonella enterica Serovar Paratyphi A and Nontyphoidal S. Typhimurium. Elhadad D; Desai P; Grassl GA; McClelland M; Rahav G; Gal-Mor O Infect Immun; 2016 Apr; 84(4):1150-1165. PubMed ID: 26857569 [TBL] [Abstract][Full Text] [Related]
14. Modulation of Yu X-J; Xie H; Li Y; Liu M; Hou R; Predeus AV; Perez Sepulveda BM; Hinton JCD; Holden DW; Thurston TLM mBio; 2024 Jul; 15(7):e0112824. PubMed ID: 38904384 [TBL] [Abstract][Full Text] [Related]
15. Harmine, an inhibitor of the type III secretion system of Shi Y; Chen X; Shu J; Liu Y; Zhang Y; Lv Q; Wang J; Deng X; Liu H; Qiu J Front Cell Infect Microbiol; 2022; 12():967149. PubMed ID: 36176578 [TBL] [Abstract][Full Text] [Related]
16. The Salmonella pathogenicity island 1 and Salmonella pathogenicity island 2 type III secretion systems play a major role in pathogenesis of systemic disease and gastrointestinal tract colonization of Salmonella enterica serovar Typhimurium in the chicken. Jones MA; Hulme SD; Barrow PA; Wigley P Avian Pathol; 2007 Jun; 36(3):199-203. PubMed ID: 17497331 [TBL] [Abstract][Full Text] [Related]
17. The Salmonella pathogenicity island (SPI)-2 and SPI-1 type III secretion systems allow Salmonella serovar typhimurium to trigger colitis via MyD88-dependent and MyD88-independent mechanisms. Hapfelmeier S; Stecher B; Barthel M; Kremer M; Müller AJ; Heikenwalder M; Stallmach T; Hensel M; Pfeffer K; Akira S; Hardt WD J Immunol; 2005 Feb; 174(3):1675-85. PubMed ID: 15661931 [TBL] [Abstract][Full Text] [Related]
18. The Interplay between Hausmann A; Hardt WD Microbiol Spectr; 2019 Mar; 7(2):. PubMed ID: 30953432 [TBL] [Abstract][Full Text] [Related]
19. Genetic Determinants in Salmonella enterica Serotype Typhimurium Required for Overcoming Mandal RK; Jiang T; Kwon YM Microbiol Spectr; 2021 Dec; 9(3):e0015521. PubMed ID: 34878334 [TBL] [Abstract][Full Text] [Related]
20. Host metabolic shift during systemic Wang Y; Wu C; Gao J; Du X; Chen X; Zhang M Emerg Microbes Infect; 2021 Dec; 10(1):1849-1861. PubMed ID: 34461813 [No Abstract] [Full Text] [Related] [Next] [New Search]